Elekta and Royal Philips announced that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI)-guided radiation therapy system.

A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances of survival, said researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).

June 18, 2014 — Researchers at Sandia National Laboratories, along with collaborators from Rice University and the Tokyo Institute of Technology, are developing new terahertz detectors based on carbon nanotubes that could lead to significant improvements in medical imaging, airport passenger screening, food inspection and other applications.

June 18, 2014 — A new molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for prostate cancer patients, said researchers at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

June 17, 2014 — Navidea Biopharmaceuticals Inc. announced results from a post-hoc analysis of patient data from the company’s phase III clinical trial (NEO3-06) of Lymphoseek in head and neck cancer.

June 17, 2014 — A total of 16 pioneering medical innovations were showcased in front of approximately 4,000 healthcare providers and experts at Premier Inc.'s sixth annual Innovation Celebration, such as the world's first and only intravenous implantable cardiac defibrillator (ICD).

June 16, 2014 — Piramal Imaging released details from research presented at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. Research findings relating to the development and approval of Neuraceq (florbetaben F18 injection) were presented during the AD II: Advanced Approaches Session.

Mammography Late-Stage Breast Cancers University of Michigan Study

In the last 30 years, since mammography was introduced, late-stage breast cancer incidence has decreased by 37 percent, a new study from the University of Michigan Comprehensive Cancer Center finds.

 

June 16, 2014 — Carestream’s Smart Link helps ensure optimal system performance and uptime by continuously monitoring operations of its healthcare IT and digital imaging systems at healthcare providers across the globe. Smart Link is provided as part of Carestream’s customer service maintenance agreements.

Smart Link real-time monitoring

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now